A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/34 (2006.01) A61K 47/08 (2006.01) A61K 47/36 (2006.01) A61K 47/38 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2731270
Compositions and methods for treating dry age related macular degeneration (dry AMD) by administration to an intraocular location of an anti-neovascular agent (such as bevacizumab) in either a liquid or solid polymeric vehicle (or both), such as a biodegradable hyaluronic acid or PLGA (or PLA).
La présente invention concerne des compositions et des procédés pour traiter la dégénérescence maculaire liée à lâge sèche (DMLA sèche) par administration à un emplacement intraoculaire dun agent anti-néovascularisation (tel que le bévacizumab) dans un véhicule polymère liquide ou solide (ou les deux), tel quun acide hyaluronique biodégradable ou PLGA (ou PLA).
Blanda Wendy M.
Burke James A.
Hughes Patrick M.
Robinson Michael R.
Whitcup Scott M.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Method for treating atrophic age related macular degeneration does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating atrophic age related macular degeneration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating atrophic age related macular degeneration will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1601562